Side effects of the irritable bowel syndrome (IBS) medication Viberzi (generic: eluxadoline) may include pancreatitis in patients who have had their gallbladder removed.
Free Confidential Lawsuit Evaluation: If you or a loved one had pancreatitis from Viberzi, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.
What’s the Problem?
The U.S. Food & Drug Administration (FDA) on March 15, 2017, issued a Drug Safety Communication which stated that its review of Viberzi suggested that patients who had their gallbladders removed could experience cases of pancreatitis that were severe enough to cause hospitalization or death.
Although Viberzi has been on the market less than 2 years, it has already been linked to at least two deaths and 120 reports of serious pancreatitis.
Viberzi is manufactured by Allergan and was approved by the FDA in May 2015 for the treatment of IBS with diarrhea. It is a controlled substance similar to an opioid and can be addictive. The drug works by activating opioid receptors in the gut, which decreases bowel contractions, reducing incidents of diarrhea and alleviating abdominal pain.
FDA has received at least 120 reports of serious pancreatitis or death since it was first approved. In 76 cases, the person required hospitalization, and 2 of those patients died. The agency found that the cases of serious pancreatitis seemed to occur after only one or two doses; however, they also occurred in some patients after prolonged use.
Of the 120 cases reported, 68 included details on the patient’s gallbladder status. Of those, 56 involved patients without a gallbladder. Both deaths occurred in patients whose gallbladders had been removed.
One of the deaths was associated with severe pancreatitis, during which the victim experienced symptoms including severe abdominal pain, nausea and vomiting within an hour of taking Viberzi. Both victims died within 3 days of their first dose of the drug, according to the FDA.
“Patients should talk to your health care professional about how to control your symptoms of irritable bowel syndrome with diarrhea (IBS-D), particularly if you do not have a gallbladder,” FDA said. “Health care professionals should not prescribe Viberzi in patients who do not have a gallbladder and should consider alternative treatment options in these patients.”
The agency noted that it is working with Allergan to address safety concerns, and is urging doctors and patients to report Viberzi problems to the FDA MedWatch adverse event reporting program.
Need More Info?
If you’d like more information on these topics, please visit our Viberzi FAQ page.
Do I Have a Viberzi Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Viberzi lawsuits. We are handling individual litigation nationwide and currently accepting new pancreatitis cases in all 50 states.
Free Case Evaluation: Again, if you were injured by Viberzi side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.